华康股份 (605077)

Zhejiang Huakang Pharmaceutical Co., Ltd.

ASH

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 30304.98
  • Circulating A-Shares(W): 29942.93
  • Earnings Per Share(RMB): 0.5700
  • Net Assets Per Share(RMB): 9.9330
  • Operating Revenue(W RMB): 295902.71
  • Total Profit(W RMB): 19288.44
  • **Net Profit Attributable to Parent(W RMB) **: 16838.15
  • Net Profit Growth Rate(%): -9.91
  • Weighted Return on Equity(%): 5.2100
  • Operating Cash Flow Per Share(RMB): 1.1020
  • Undistributed Profit Per Share(RMB): 3.8178
  • Capital Reserve Per Share(RMB): 4.7004

2. Main Business

The main business covers:

  • Research, development, production, and sales of xylitol
  • Research, development, production, and sales of sorbitol
  • Research, development, production, and sales of maltitol, fructose syrup, and other functional sugar alcohols and starch sugar products.

3. Company Basic Information

  • Company Name: Zhejiang Huakang Pharmaceutical Co., Ltd.
  • Listing Date: 2021-02-09
  • Industry: Food Manufacturing
  • Address: No. 18 Huagong Road, Huabu Town, Kaihua County, Zhejiang Province
  • Website: https://www.huakangpharma.com/
  • Company Profile: On September 25, 2007, Huakang Limited held a shareholders' meeting and resolved to change the company into a joint-stock company based on the audited net assets as of September 30, 2007. On December 13, 2007, the issuer completed the industrial and commercial change registration with the Zhejiang Provincial Administration for Industry and Commerce, obtained the "Business License of Enterprise Legal Person," with both registered capital and paid-in capital of 75.02 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Fujian Yake Food Co., Ltd. General Legal Person 1451.07 4.85
2 Kaihua Jinyue Investment Management Co., Ltd. General Legal Person 425.01 1.42
3 China AMC Excellent Growth Hybrid Securities Investment Fund Class A Fund 415.33 1.39
4 Zhejiang Huiju Investment Management Co., Ltd. General Legal Person 379.00 1.27
5 Everbright Pramer Credit Enhancement Bond型 Securities Investment Fund Class A Fund 364.81 1.22

5. Concept Sectors

  • Convertible Bonds
  • Sugar Substitute Concept
  • Synthetic Biology
  • High-Performance Stocks
  • Broken Issue Price
  • Restructuring Plan

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information